ruxolitinib

signal transducer and activator of transcription 6 ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34359628 Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients. 2021 Jul 24 1
2 29203240 IL-13 regulates IL-17C expression by suppressing NF-κB-mediated transcriptional activation in airway epithelial cells. 2018 Jan 1 2
3 26811457 Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma. 2016 Feb 9 1